Interleukin-33 requires CMRF35-like molecule-1 expression for induction of myeloid cell activation

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 69, Issue 6, 2014, Pages 719-729

  Shik, D ^a   Moshkovits, I ^a   Karo Atar, D ^a   Reichman, H ^a   Munitz, A ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

CMRF 35 like molecule 1; eosinophils; IL 33

Indexed keywords

CELL SURFACE RECEPTOR; CMRF 35 LIKE MOLECULE 1; CMRF 35 LIKE MOLECULE 8; EOTAXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 33; INTERLEUKIN 5; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG; CLM-1 PROTEIN, MOUSE; CYTOKINE; IL1RL1 PROTEIN, MOUSE; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN DERIVATIVE; INTERLEUKIN RECEPTOR; INTERLEUKIN-33, MOUSE; PROTEIN BINDING;

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL ACTIVATION; CELL FUNCTION; CELL INFILTRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MAST CELL; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECTS; ENZYME ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PROTEIN TRANSPORT;

ANIMALS; CELLS, CULTURED; CYTOKINES; ENZYME ACTIVATION; EOSINOPHILS; GENE EXPRESSION; GENE EXPRESSION REGULATION; INTERLEUKINS; MACROPHAGES; MAST CELLS; MICE; MICE, KNOCKOUT; MYELOID CELLS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, IMMUNOLOGIC; RECEPTORS, INTERLEUKIN;

EID: 84899982409     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12388     Document Type: Article

References (49)

1. Liew FY, Pitman NI, McInnes IB,. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 2010; 10: 103-110.
2. Oboki K, Nakae S, Matsumoto K, Saito H,. IL-33 and airway inflammation. Allergy Asthma Immunol Res 2011; 3: 81-88.
3. Pichery M, Mirey E, Mercier P, Lefrancais E, Dujardin A, Ortega N, et al. Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J Immunol 2012; 188: 3488-3495.
4. Luthi AU, Cullen SP, McNeela EA, Duriez PJ, Afonina IS, Sheridan C, et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009; 31: 84-98.
5. Haraldsen G, Balogh J, Pollheimer J, Sponheim J, Kuchler AM,. Interleukin-33-cytokine of dual function or novel alarmin? Trends Immunol 2009; 30: 227-233.
6. Suzukawa M, Koketsu R, Iikura M, Nakae S, Matsumoto K, Nagase H, et al. Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils. Lab Invest 2008; 88: 1245-1253.
7. Suzukawa M, Iikura M, Koketsu R, Nagase H, Tamura C, Komiya A, et al. An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J Immunol 2008; 181: 5981-5989.
8. Barlow JL, Peel S, Fox J, Panova V, Hardman CS, Camelo A, et al. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J Allergy Clin Immunol 2013; 132: 933-941.
9. Hung LY, Lewkowich IP, Dawson LA, Downey J, Yang Y, Smith DE, et al. IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms. Proc Natl Acad Sci U S A 2013; 110: 282-287.
10. Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 2010; 363: 1211-1221.
11. Lee SM, Suk K, Lee WH,. Synthetic peptides containing ITIM-like sequences of IREM-1 (CD300F) differentially regulate MyD88 and TRIF-mediated TLR signalling through activation of SHP and/or PI3K. Clin Exp Immunol 2012; 167: 438-446.
12. Lee SM, Kim EJ, Suk K, Lee WH,. CD300F blocks both MyD88 and TRIF-mediated TLR signaling through activation of Src homology region 2 domain-containing phosphatase 1. J Immunol 2011; 186: 6296-6303.
13. Clark GJ, Ju X, Tate C, Hart DN,. The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions. Trends Immunol 2009; 30: 209-217.
14. Izawa K, Kitaura J, Yamanishi Y, Matsuoka T, Kaitani A, Sugiuchi M, et al. An activating and inhibitory signal from an inhibitory receptor LMIR3/CLM-1: LMIR3 augments lipopolysaccharide response through association with FcRgamma in mast cells. J Immunol 2009; 183: 925-936.
15. Alvarez-Errico D, Sayos J, Lopez-Botet M,. The IREM-1 (CD300f) inhibitory receptor associates with the p85alpha subunit of phosphoinositide 3-kinase. J Immunol 2007; 178: 808-816.
16. Moshkovits I, Shik D, Itan M, Karo-Atar D, Bernshtein B, Hershko AY, et al. CMRF35-like molecule 1 (CLM-1) regulates eosinophil homeostasis by suppressing cellular chemotaxis. Mucosal Immunol 2014; 7: 292-303.
17. Bustamante CD, Fledel-Alon A, Williamson S, Nielsen R, Hubisz MT, Glanowski S, et al. Natural selection on protein-coding genes in the human genome. Nature 2005; 437: 1153-1157.
18. Xi H, Katschke KJ Jr, Helmy KY, Wark PA, Kljavin N, Clark H, et al. Negative regulation of autoimmune demyelination by the inhibitory receptor CLM-1. J Exp Med 2010; 207: 7-16.
19. Dyer KD, Moser JM, Czapiga M, Siegel SJ, Percopo CM, Rosenberg HF,. Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow. J Immunol 2008; 181: 4004-4009.
20. Karo-Atar D, Moshkovits I, Eickelberg O, Konigshoff M, Munitz A,. Paired immunoglobulin-like receptor-B inhibits pulmonary fibrosis by suppressing profibrogenic properties of alveolar macrophages. Am J Respir Cell Mol Biol 2013; 48: 456-464.
21. Munitz A, Cole ET, Beichler A, Groschwitz K, Ahrens R, Steinbrecher K, et al. Paired immunoglobulin-like receptor B (PIR-B) negatively regulates macrophage activation in experimental colitis. Gastroenterology 2010; 139: 530-541.
22. Bachelet I, Munitz A, Levi-Schaffer F,. Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a. J Allergy Clin Immunol 2006; 117: 1314-1320.
23. Krutzik PO, Nolan GP,. Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry A 2003; 55: 61-70.
24. Bolte S, Cordelieres FP,. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 2006; 224: 213-232.
25. Bachelet I, Munitz A, Moretta A, Moretta L, Levi-Schaffer F,. The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells. J Immunol 2005; 175: 7989-7995.
26. Borrego F,. The CD300 molecules: an emerging family of regulators of the immune system. Blood 2013; 121: 1951-1960.
27. Chung DH, Humphrey MB, Nakamura MC, Ginzinger DG, Seaman WE, Daws MR,. CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation. J Immunol 2003; 171: 6541-6548.
28. Kurowska-Stolarska M, Stolarski B, Kewin P, Murphy G, Corrigan CJ, Ying S, et al. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol 2009; 183: 6469-6477.
29. Komai-Koma M, Brombacher F, Pushparaj PN, Arendse B, McSharry C, Alexander J, et al. Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naive mice. Allergy 2012; 67: 1118-1126.
30. Cormier SA, Taranova AG, Bedient C, Nguyen T, Protheroe C, Pero R, et al. Pivotal advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukoc Biol 2006; 79: 1131-1139.
31. Yasuda K, Muto T, Kawagoe T, Matsumoto M, Sasaki Y, Matsushita K, et al. Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc Natl Acad Sci U S A 2012; 109: 3451-3456.
32. Licona-Limon P, Kim LK, Palm NW, Flavell RA,. TH2, allergy and group 2 innate lymphoid cells. Nat Immunol 2013; 14: 536-542.
33. Liu X, Li M, Wu Y, Zhou Y, Zeng L, Huang T,. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochem Biophys Res Commun 2009; 386: 181-185.
34. Alvarez-Errico D, Aguilar H, Kitzig F, Brckalo T, Sayos J, Lopez-Botet M,. IREM-1 is a novel inhibitory receptor expressed by myeloid cells. Eur J Immunol 2004; 34: 3690-3701.
35. Marquez JA, Galfre E, Dupeux F, Flot D, Moran O, Dimasi N,. The crystal structure of the extracellular domain of the inhibitor receptor expressed on myeloid cells IREM-1. J Mol Biol 2007; 367: 310-318.
36. Lee SM, Nam YP, Suk K, Lee WH,. Immune receptor expressed on myeloid cells 1 (IREM-1) inhibits B cell activation factor (BAFF)-mediated inflammatory regulation of THP-1 cells through modulation of the activities of extracellular regulated kinase (ERK). Clin Exp Immunol 2010; 161: 504-511.
37. Fujimoto M, Takatsu H, Ohno H,. CMRF-35-like molecule-5 constitutes novel paired receptors, with CMRF-35-like molecule-1, to transduce activation signal upon association with FcRgamma. Int Immunol 2006; 18: 1499-1508.
38. Sidorenko SP, Clark EA,. The dual-function CD150 receptor subfamily: the viral attraction. Nat Immunol 2003; 4: 19-24.
39. Izawa K, Yamanishi Y, Maehara A, Takahashi M, Isobe M, Ito S, et al. The receptor LMIR3 negatively regulates mast cell activation and allergic responses by binding to extracellular ceramide. Immunity 2012; 37: 827-839.
40. Martinez-Barriocanal A, Comas-Casellas E, Schwartz S Jr, Martin M, Sayos J,. CD300 heterocomplexes, a new and family-restricted mechanism for myeloid cell signaling regulation. J Biol Chem 2010; 285: 41781-41794.
41. Kouzaki H, Iijima K, Kobayashi T, O'Grady SM, Kita H,. The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. J Immunol 2011; 186: 4375-4387.
42. Choi SC, Simhadri VR, Tian L, Gil-Krzewska A, Krzewski K, Borrego F, et al. Cutting edge: mouse CD300f (CMRF-35-like molecule-1) recognizes outer membrane-exposed phosphatidylserine and can promote phagocytosis. J Immunol 2011; 187: 3483-3487.
43. Murray PJ, Wynn TA,. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011; 11: 723-737.
44. Lee JJ, Jacobsen EA, McGarry MP, Schleimer RP, Lee NA,. Eosinophils in health and disease: the LIAR hypothesis. Clin Exp Allergy 2010; 40: 563-575.
45. Nakayama M, Underhill DM, Petersen TW, Li B, Kitamura T, Takai T, et al. Paired Ig-like receptors bind to bacteria and shape TLR-mediated cytokine production. J Immunol 2007; 178: 4250-4259.
46. Pereira S, Lowell C,. The Lyn tyrosine kinase negatively regulates neutrophil integrin signaling. J Immunol 2003; 171: 1319-1327.
47. Munitz A, McBride ML, Bernstein JS, Rothenberg ME,. A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils. Blood 2008; 111: 5694-5703.
48. Zhang H, Meng F, Chu CL, Takai T, Lowell CA,. The Src family kinases Hck and Fgr negatively regulate neutrophil and dendritic cell chemokine signaling via PIR-B. Immunity 2005; 22: 235-246.
49. Baruch-Morgenstern NB, Shik D, Moshkovits I, Itan M, Karo-Atar D, Bouffi C, et al. Paired immunoglobulin-like receptor A is an intrinsic, self-limiting suppressor of IL-5-induced eosinophil development. Nat Immunol 2013; 15: 36-44.